Stock ROQ ROQUEFORT THERAPEUTICS PLC
Add to a list
To use this feature you must be a member
Log inSign up

Highlights Roquefort Therapeutics plc

Equities

ROQ

GB00BMDQ2T15

Market Closed - London S.E.
Other stock markets
 09:05:22 31/05/2024 pm IST 		5-day change 1st Jan Change
5 GBX -4.76% Intraday chart for Roquefort Therapeutics plc -9.09% -31.03%
23/05 Windward wins deal; Kodal progresses at Bougouni AN
23/05 Roquefort Therapeutics plc Announces Executive and Board Changes CI

Highlights

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Windward wins deal; Kodal progresses at Bougouni
AN
EARNINGS AND TRADING: Aura confident in Tiris; Cindrigo enters Germany
AN
Earnings Flash (ROQ.L) ROQUEFORT THERAPEUTICS Reports FY23 Loss GBX-1.35
MT
Roquefort Therapeutics plc Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Roquefort celebrates "significant milestones" in cancer research
AN
Roquefort Therapeutics plc Provides an Update on the Development of the Midkine Midkine mRNA and STAT-6 siRNA programs
CI
Roquefort hails further MK studies, licence talks continue
AN
Roquefort Therapeutics plc Provides an Update on Its Pre-Clinical Drug Development Programs
CI
Roquefort Therapeutics Announces Significant Mesodermal Killer Cell Milestone
CI
EARNINGS: Biome loss widens; Amicorp focused on growth post-IPO
AN
Roquefort Therapeutics plc Reports Earnings Results for the Half Year Ended June 30, 2023
CI
Roquefort Therapeutics Files International Patent for Anti-cancer Therapeutics
MT
Roquefort Therapeutics plc Announces the Successful Filing of the International Phase PCT Patent for Its Proprietary Anti-Cancer mRNA and RNA Oligonucleotide Therapeutics
CI
Anpario trading in line, Likewise Group sales rise
AN
Roquefort says anti-cancer mRNA study shows positive results
AN
Roquefort Therapeutics loss widens as administrative costs go up
AN
Earnings Flash (ROQ.L) ROQUEFORT THERAPEUTICS Posts FY22 Loss GBX-1.56
MT
Roquefort Therapeutics plc Reports Earnings Results for the Full Year Ended December 31, 2022
CI
Roquefort Therapeutics announces new anti-cancer platform
AN
Roquefort Therapeutics plc Announces Creation of New Novel Family of mRNA Therapeutics
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. ROQ Stock
  4. News Roquefort Therapeutics plc
  5. Highlights